trial · primary record
Simenafil Hydrochloride Tablets 2.5 mg
Alzheimer Disease
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 200 |
| Primary completion | 2028-12 |
| Primary endpoint | Clinical Dementia Rating Scale-Sum of Boxes (CDR-SB) |
| Registry ID | NCT07905352 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:31:54.065Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07905352
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.